Lainie Jones Comprehensive Cancer Survivorship Act of 2026

H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839/S.502 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. H.R. 8339: Drug Origin Transparency Act to amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting H.R. 5526/S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521/S. 4440: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839/S. 5052: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Provide input regarding contents and legislative strategy related to Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839, introduced in 119th Congress.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivors background, or forthcoming survivorship needs, and for other purposes. H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes. H.Res.1196 - Recognizing April as Cancer Prevention and Early Detection Month; a House resolution to recognize April as Cancer Prevention and Early Detection month Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance Comments related the CMS Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model and Medicares six protected classes

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), White House Office

H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lainie Jones Comprehensive Cancer Survivorship Act (CCSA) H.R. 8839

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES

H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. H.R. 8339: Drug Origin Transparency Act to amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting H.R. 5526/S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521/S. 4440: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors.

Client expense: $480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE